Dicerna Pharmaceuticals

Founded2007
Team size51-200
HQLexington, United States

About Dicerna Pharmaceuticals

Dicerna, a wholly owned subsidiary of Novo Nordisk, is focused on driving innovation in RNAi (ribonucleic acid interference) to selectively target and silence genes that cause or contribute to disease.

Company at a glance

Location
Lexington, United States

Location

Frequently asked questions